| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12094-011-0611-3 |
| P698 | PubMed publication ID | 21239350 |
| P2093 | author name string | Miguel Quintanilla | |
| Raquel del Moral | |||
| Carolina Belmar-Lopez | |||
| Pilar Martin-Duque | |||
| Camino Latorre-Romero | |||
| Margarita R Marin-Yaseli | |||
| Pedro C Marijuan | |||
| P2860 | cites work | Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure | Q24634002 |
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. | Q30157916 | ||
| Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins | Q33331623 | ||
| Transplant outcomes in acute leukemia. I. | Q33621502 | ||
| Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta | Q33855709 | ||
| Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma | Q33881828 | ||
| Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses | Q33924550 | ||
| Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells | Q34154904 | ||
| Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? | Q34225918 | ||
| Gliomagenesis and the use of neural stem cells in brain tumor treatment | Q34310698 | ||
| Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy | Q34496174 | ||
| Acute promyelocytic leukemia: evolving therapeutic strategies | Q34503964 | ||
| Bone-marrow transplantation (first of two parts). | Q34649003 | ||
| Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment | Q35087261 | ||
| A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas | Q35632469 | ||
| The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. | Q35899034 | ||
| Adult stem cells in the treatment of autoimmune diseases | Q36508132 | ||
| Multipotent adult progenitor cell and stem cell plasticity | Q36667441 | ||
| Hematopoietic cell transplantation for chronic lymphocytic leukemia: an evolving concept | Q36768631 | ||
| Recent advances into the understanding of mesenchymal stem cell trafficking | Q36835893 | ||
| Potential of tumour cells for delivering oncolytic viruses | Q37115398 | ||
| Cancer immunotherapy by dendritic cells | Q37272237 | ||
| Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. | Q37390890 | ||
| Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas | Q37461117 | ||
| Hypoxia and pluripotency in embryonic and embryonal carcinoma stem cell biology. | Q37552202 | ||
| Stem cells as vectors for antitumour therapy | Q37730300 | ||
| The impact of molecularly targeted therapies upon the understanding of leukemogenesis and the role of hematopoietic stem cell transplantation in acute promyelocytic leukemia | Q37763245 | ||
| Pluripotent stem cell-derived natural killer cells for cancer therapy | Q37783804 | ||
| Isolation procedure and characterization of multipotent adult progenitor cells from rat bone marrow | Q39723073 | ||
| Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells | Q39753209 | ||
| Identification of gliotropic factors that induce human stem cell migration to malignant tumor | Q39863377 | ||
| Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium | Q39863427 | ||
| Neural stem cell tropism to glioma: critical role of tumor hypoxia. | Q39906167 | ||
| Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy. | Q39958215 | ||
| Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma | Q40025607 | ||
| Systemic dissemination of viral vectors during intratumoral injection | Q40616320 | ||
| Migration of mesenchymal stem cells to heart allografts during chronic rejection | Q40663512 | ||
| Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy | Q40738121 | ||
| Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector | Q43439877 | ||
| Phenotypic correction of Fanconi anemia group C knockout mice. | Q45864476 | ||
| Enhanced local delivery with reduced systemic toxicity: delivery, delivery, and delivery. | Q45865369 | ||
| Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients | Q45866834 | ||
| T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. | Q45866838 | ||
| Blood clearance rates of adenovirus type 5 in mice | Q45871684 | ||
| Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep | Q45872229 | ||
| New non-viral method for gene transfer into primary cells. | Q45875106 | ||
| Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. | Q46917405 | ||
| Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain | Q48522798 | ||
| Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. | Q50107871 | ||
| Multipotent adult progenitor cell isolation and culture procedures. | Q51117641 | ||
| Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99 | Q58069392 | ||
| Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors | Q64378688 | ||
| Bone marrow transplantation | Q72258978 | ||
| Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program | Q73586024 | ||
| Highly proliferative intratumoral fibroblasts and a high proliferative microvessel index are significant predictors of tumor metastasis in T3 ulcerative-type colorectal cancer | Q73826186 | ||
| Perspectives in gene therapy | Q74224702 | ||
| Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma | Q74527302 | ||
| Mesenchymal stem cells in osteobiology and applied bone regeneration | Q77902271 | ||
| Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells | Q80077858 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 10-17 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Clinical and Translational Oncology | Q15754324 |
| P1476 | title | Using living cells to transport therapeutic genes for cancer treatment | |
| P478 | volume | 13 |
| Q39921284 | Monocyte cell membrane-derived nanoghosts for targeted cancer therapy | cites work | P2860 |
Search more.